Am. J. Respir. Crit. Care Med., Vol 151, No. 3, Mar 1995, 773-779.
N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation
K Reinhart, CD Spies, A Meier-Hellmann, DL Bredle, L Hannemann, M Specht and W Schaffartzik
Department of Anesthesia and Intensive Care Medicine, Steglitz Medical Center, Free University Berlin, Germany.
Hyperoxic ventilation, used to prevent hypoxemia during potential periods
of hypoventilation, has been reported to paradoxically decrease whole body
oxygen consumption (VO2). Reduction in nutritive blood flow due to oxygen
radical production is one possible mechanism. We investigated whether
pretreatment with the sulfhydryl group donor and O2 radical scavenger
N-acetylcysteine (NAC) would preserve whole body VO2 and prevent
deterioration of oxygenation in gastric mucosal tissue during hyperoxia.
Thirty-eight patients, requiring hemodynamic monitoring (radial and
pulmonary artery catheters) due to sepsis syndrome, were included in this
randomized experiment. All patients exhibited stable clinical conditions
(hemodynamics, body temperature, hemoglobin, FIO2 < 0.5). A gastric
tonometer was placed to measure the gastric intramucosal pH (pHi), which
indirectly assesses nutritive blood flow to the mucosa. Cardiac output was
determined by thermodilution and VO2 by cardiovascular Fick. After baseline
measurements, patients randomly received either 150 mg.kg-1 NAC (n = 19) or
placebo (n = 19) in 250 ml 5% dextrose intravenously over a period of 15
min. Measurements were repeated 30 min after starting NAC or placebo
infusion, 30 min after starting hyperoxia (FIO2 = 1.0), and 60 min after
resetting the original FIO2. There were no significant differences between
groups in any of the measurements before treatment and after the return to
baseline FIO2 at the end of the study. NAC, but not placebo infusion,
caused a slight but significant increase in cardiac output and decrease in
systemic vascular resistance.(ABSTRACT TRUNCATED AT 250 WORDS)